Detalhe da pesquisa
1.
Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations.
Gynecol Oncol
; 134(3): 599-606, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24995579
2.
Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome.
Br J Cancer
; 106(10): 1682-8, 2012 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22415229
3.
KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer.
Br J Cancer
; 107(12): 1997-2004, 2012 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23099803
4.
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation.
Proc Natl Acad Sci U S A
; 106(12): 4834-9, 2009 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-19261849
5.
High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer.
Br J Cancer
; 104(6): 921-6, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21343929
6.
Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples.
Mol Psychiatry
; 15(5): 463-72, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18936756
7.
Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
Mol Psychiatry
; 14(3): 308-17, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18195716
8.
Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?
Pharmacogenomics J
; 5(5): 298-304, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16027736